Loss of GD1-positive <i>Lactobacillus</i> correlates with inflammation in human lungs with COPD

Abstract

A reduction in GD1 positivity is associated with an increased tissue immune inflammatory response in early stage COPD. There is potential for Lactobacillus to be used as a possible therapeutic, however, validation of these results need to be completed before an anti-inflammatory role of Lactobacillus in COPD can be confirmed.